Combination therapy
Clinical trials for Combination therapy explained in plain language.
Never miss a new study
Get alerted when new Combination therapy trials appear
Sign up with your email to follow new studies for Combination therapy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a metabolic modulator help people with type 1 diabetes use insulin better?
Disease control Recruiting nowThis study tests whether a drug called AMX0035 can improve how the body responds to insulin in adults with type 1 diabetes. Participants take either AMX0035 or a placebo daily for 24 weeks. Researchers measure insulin sensitivity using a glucose clamp test and track blood sugar c…
Matched conditions: COMBINATION THERAPY
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New antibody combo targets tough lymphoma in early trial
Disease control Recruiting nowThis study tests a new drug called EMB-07, which is a bispecific antibody that helps the immune system attack cancer cells. It is for people with aggressive B-cell non-Hodgkin lymphoma, either newly diagnosed or whose cancer has come back. The trial will check safety, side effect…
Matched conditions: COMBINATION THERAPY
Phase 1/2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC